The SURFeye project of advanced ocular surface therapy, in which BTI has participated, concludes

The 'SURFeye' project has completed its path, after three years of research in the area of ocular surface pathologies, developing advanced therapies and diagnostic systems for diseases of the ocular surface.

In order to carry out the project, a consortium composed of a group of companies was set up, with outstanding participation of BTI Biotechnology Institute, the Fernández-Vega Ophthalmological Research Foundation and the public centers University of Santiago de Compostela and University of the Basque Country.

 More information

The news in the media:
Infosalus El Economista La Información
Diario Siglo XXI Saludigestivo Bolsamanía
Sabor 809 Diario Multimedia La Voz Libre
Medicina TV    


Are you interested in contacting us?